Scholars@Duke publication: Schedule-dependent activity of irinotecan plus BCNU against malignant glioma xenografts (vol 45, pg 345, 1999)

Schedule-dependent activity of irinotecan plus BCNU against malignant glioma xenografts (vol 45, pg 345, 1999)

Publication , Journal Article

Friedman, HS; Castellino, RC; Elion, GB; Keir, ST; Houghton, PJ; Johnson, SP; Bigner, DD

Published in: CANCER CHEMOTHERAPY AND PHARMACOLOGY

July 1, 2000

CANCER CHEMOTHERAPY AND PHARMACOLOGY

0344-5704

July 1, 2000

84 / 84

SPRINGER VERLAG

APA

Chicago

ICMJE

MLA

NLM

Friedman, H. S., Castellino, R. C., Elion, G. B., Keir, S. T., Houghton, P. J., Johnson, S. P., & Bigner, D. D. (2000). Schedule-dependent activity of irinotecan plus BCNU against malignant glioma xenografts (vol 45, pg 345, 1999). CANCER CHEMOTHERAPY AND PHARMACOLOGY, 46(1), 84–84.

Friedman, H. S., R. C. Castellino, G. B. Elion, S. T. Keir, P. J. Houghton, S. P. Johnson, and D. D. Bigner. “Schedule-dependent activity of irinotecan plus BCNU against malignant glioma xenografts (vol 45, pg 345, 1999).” CANCER CHEMOTHERAPY AND PHARMACOLOGY 46, no. 1 (July 1, 2000): 84–84.

Friedman HS, Castellino RC, Elion GB, Keir ST, Houghton PJ, Johnson SP, et al. Schedule-dependent activity of irinotecan plus BCNU against malignant glioma xenografts (vol 45, pg 345, 1999). CANCER CHEMOTHERAPY AND PHARMACOLOGY. 2000 Jul 1;46(1):84–84.

Friedman, H. S., et al. “Schedule-dependent activity of irinotecan plus BCNU against malignant glioma xenografts (vol 45, pg 345, 1999).” CANCER CHEMOTHERAPY AND PHARMACOLOGY, vol. 46, no. 1, SPRINGER VERLAG, July 2000, pp. 84–84.

Friedman HS, Castellino RC, Elion GB, Keir ST, Houghton PJ, Johnson SP, Bigner DD. Schedule-dependent activity of irinotecan plus BCNU against malignant glioma xenografts (vol 45, pg 345, 1999). CANCER CHEMOTHERAPY AND PHARMACOLOGY. SPRINGER VERLAG; 2000 Jul 1;46(1):84–84.

CANCER CHEMOTHERAPY AND PHARMACOLOGY

0344-5704

July 1, 2000

84 / 84

SPRINGER VERLAG